Wenhao Luo

18PUBLICATIONS
18CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersCancer diagnosisEpidemiological modellingHistory of economic thought
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|Jun 21, 2026
Nab-paclitaxel plus S-1 induction chemotherapy for patients with locally advanced pancreatic cancer: a multicenter, open-label phase 2 study.

|Jun 11, 2025
SPP1+ Venous Endothelial Cells and CRABP2+ Tumor Cells Contribute to Favorable Body and Tail Pancreatic Ductal Adenocarcinoma Tumor Microenvironment.

Yueze Liu, Yifan Fu, Tao Liu

|Jun 27, 2024
Impact of Combined Chemotherapy and Targeted Therapy on Pancreatic Neuroendocrine Carcinoma with Liver Metastasis: A Single-Center Modified Nomogram Analysis.

Wenhao Luo, Hao Chen, Taiping Zhang

|Jun 26, 2024
Human Equilibrative Nucleoside Transporter 1: Novel Biomarker and Prognostic Indicator for Patients with Gemcitabine-Treated Pancreatic Cancer.

Jianchun Xiao, Fangyu Zhao, Wenhao Luo

|May 22, 2024
FBXO32 Stimulates Protein Synthesis to Drive Pancreatic Cancer Progression and Metastasis.

Dan Su, Ruobing Wang, Guangyu Chen

|Sep 03, 2022
Letter to the editor: HCC EV ECG score: An extracellular vesicle-based protein assay for detection of early-stage HCC.

Wenhao Luo, Yu Gu, Taiping Zhang

Pageof 3

Frequent Collaborators

3 joint publications

Taiping Zhang

1 joint publications

Yang Guo

1 joint publications

Pei-Dong Zhang

1 joint publications

Ying Zhang